Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released Aug 9, 2018, after the close
10-Q filed Aug 9, 2018, 40 days after period end · 0000320017-18-000112
| Metric | Q2 2017 | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|---|
| Revenue | — | — | $8.30M | $5.87M |
| Net Income | -$4.08M | $38.47M | -$7.88M | -$17.13K |
| EPS Diluted |
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
| -$0.42 |
| $4.34 |
| -$1.33 |
| -$3.84 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
